Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
249.68Price to Earnings
VS
Market
Sector
Industry
History
$ 11.15Close
$ 6.56 - $ 12.79 52-Week Range
Ticker Information
Ticker
ZVRACompany Name
ZEVRA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQZEVRA THERAPEUTICS INC - Price to Earnings Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ZVRA - P/E Historical data
| Date | Market Capitalization | Net Income Common Stock | Price to Earnings |
|---|---|---|---|
| 6/30/2025 | $ 660.15M | $ 2.64M | 249.68 |
| 3/31/2025 | $ 430.33M | $ -91.99M | 0 |
| 12/31/2024 | $ 428.6M | $ -105.51M | 0 |
| 9/30/2024 | $ 462.24M | $ -84.92M | 0 |
| 6/30/2024 | $ 367.8M | $ -65.75M | 0 |
| 3/31/2024 | $ 210.52M | $ -50.9M | 0 |
| 12/31/2023 | $ 224.08M | $ -46.05M | 0 |
| 9/30/2023 | $ 159.36M | $ -39.92M | 0 |
| 6/30/2023 | $ 183.24M | $ -32.49M | 0 |
| 3/31/2023 | $ 147.72M | $ -51.45M | 0 |
Key Performance Insights, Last 5 Years
- ZEVRA THERAPEUTICS INC's latest trailing twelve months (TTM) P/E stands at 0.
- Over the past 5 years, ZEVRA THERAPEUTICS INC's average P/E has been 249.68.
- The median P/E for ZEVRA THERAPEUTICS INC during this period was 249.68
- ZEVRA THERAPEUTICS INC reached its highest P/E over the past 5 years at 249.68.
- The lowest P/E recorded by ZEVRA THERAPEUTICS INC in the same timeframe 249.68
ZEVRA THERAPEUTICS INC's P/E vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/E Benchmarks
Similar metrics to P/E:
- Earnings Yield - [Calculation] The Earnings Yield, also known as the inverse of the PE ratio [PE], expresses a company’s earnings [NetIncCmn] as a percentage of [MarketCap].
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
Definition of Price to Earnings
[Calculation] Measures a company’s [MarketCap] in relation to its Net Income [NetIncCmn]. A high P/E ratio indicates that investors anticipate greater future earnings growth compared to companies with a lower P/E.Market Cap / Net Inc. Cmn.
(=) P/E P/E for ZEVRA THERAPEUTICS INC is calculated as follows: Market Cap [ $ 41.35M ] / Net Inc. Cmn. [ $ -13.94M ]
(=) P/E [ 0 ] ZVRA - Price to Earnings, Last 5 years
249.68
Minimum
Jun 30, 2025
249.68
Maximum
Jun 30, 2025
249.68
Average
249.68
Median
P/E Benchmark AnalysisMarket
The chart above depicts the distribution of P/E for companies in the Total Stock Market. The average P/E of the companies is 22.54 with a standard deviation of 14.
The following table provides additional summary stats:
P/E in the Market:
| filtered constituents | 2.08K |
|---|---|
| min | 0.13 |
| max | 70.48 |
| average | 22.54 |
| median | 18.89 |
| std | 14 |